Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 07/20 02:47:58 pm
92.015 EUR   -0.36%
09:06aBattle lines drawn as EU court weighs fate of gene-edited crops
RE
07/12Lanxess water treatment unit attracts interest - sources
RE
07/11BAYER : Still trending down
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer : 520-18-1-233-0008-MedRad

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/03/2017 | 01:54pm CEST

Document Type: Award Notice

Posted Date: 02-OCT-17

Location: Department of Veterans Affairs, VA Gulf Coast Veterans Health Care System, Department of Veterans Affairs Gulf Coast Veterans Health Care System

Classification Code: J - Maintenance, repair & rebuilding of equipment

Subject: 520-18-1-233-0008-MedRad

Solicitation Number: VA25617Q1137

Internet Link: https://www.fbo.gov/index?s=opportunity&mode=form&id=211473108a0fe6146b4fc51fd305a6c4&tab=documents&tabmode=list

Copyright (c) 2017 Federal Information & News Dispatch, Inc., source Federal Documents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
09:06aBattle lines drawn as EU court weighs fate of gene-edited crops
RE
01:35aBAYER : Reports from Bayer Add New Data to Findings in Head and Neck Cancer (EGF..
AQ
07/19REPORTS FROM BAYER PROVIDE NEW INSIG : Bioavailability, Excretion,...
AQ
07/12BAYER : Findings from Bayer in the Area of Medical Statistics Described (A Bayes..
AQ
07/12Lanxess water treatment unit attracts interest - sources
RE
07/10BAYER : U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial
RE
07/06BAYER : expands strategic alliance with Broad Institute of MIT and Harvard
AQ
07/06BAYER : Greenberg Traurig Advised Tecnoquimicas on Acquisition of MK Generics Bu..
AQ
07/05BAYER : Findings from Bayer Reveals New Findings on Personalized Medicine (Recen..
AQ
07/04Thyssenkrupp, Tata Steel may need asset sales to get EU nod for JV
RE
More news
News from SeekingAlpha
02:36aAllergan's Big Win For 12-Week Wet AMD Dosing With Abicipar May Be Enough To .. 
07/123 THINGS IN BIOTECH, JULY 12 : Immunotherapy Brawl, And A Creeper In The Weeds 
07/10Judge says lawsuits alleging Roundup weedkiller causes cancer can go to trial 
07/05Bayer Animal Health in-licenses IP from Mitsui Chemicals Agro for parasiticid.. 
07/03YOUR DAILY PHARMA SCOOP : Redhill's New Patent, Nuvectra Slips, Teligent Gains 
Financials (€)
Sales 2018 39 172 M
EBIT 2018 7 777 M
Net income 2018 4 973 M
Debt 2018 33 269 M
Yield 2018 3,00%
P/E ratio 2018 18,67
P/E ratio 2019 16,60
EV / Sales 2018 3,06x
EV / Sales 2019 2,54x
Capitalization 86 690 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 116 €
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-9.77%101 133
JOHNSON & JOHNSON-8.53%342 779
PFIZER3.98%220 295
NOVARTIS-1.75%206 001
ROCHE HOLDING LTD.-5.90%203 399
MERCK AND COMPANY11.09%169 328